Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.07
Delayed Data
As of Jul 22
 -0.023 / -2.10%
Today’s Change
0.64
Today|||52-Week Range
1.99
-24.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.7M

Company Description

XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program, focuses on the treatment of Systemic lupus erythematosus (SLE). The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.

Contact Information

XTL Biopharmaceuticals Ltd.
5 HaCharoshet Street
Raanana Hamerkaz 43656
P:(729) 955-7080
Investor Relations:

Employees

Shareholders

Other institutional7.71%
Mutual fund holders1.26%
Individual stakeholders--

Top Executives

Joshua LevineChief Executive Officer
David KestenbaumChief Financial Officer
Daphna ParanMedical Director